title: [Do the new drugs improve prognosis of stage IV NSCLC?].
authors.affiliation: UF d'Oncologie pulmonaire, Hôpital Tenon, 4, rue de la Chine, 75020 Paris.
authors.forename: B
authors.initials: B
authors.lastname: Milleron
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents